Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of PK-guided prophylaxis on clinical outcomes and FVIII consumption for patients with moderate to severe Haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 06, 2023
Real-world study of rurioctocog alfa pegol and emicizumab in US clinical practice among patients with hemophilia A.
Journal: Expert review of hematology
Published: August 24, 2022
Treatment of Congenital Afibrinogenemia in a Neonate With Critical Pulmonary Stenosis.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
Published: December 08, 2021
SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature.
Journal: Journal of pediatric hematology/oncology
Published: July 28, 2021
Unusually High Prevalence of Stroke and Cerebral Vasculopathy in Hemoglobin SC Disease: A Retrospective Single Institution Study.
Journal: Acta haematologica
Published: January 10, 2021
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A.
Journal: Journal of medical economics
Published: September 24, 2020
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup.
Journal: Clinical pharmacokinetics
Published: August 23, 2019
Switching patients in the age of long-acting recombinant products?
Journal: Expert review of hematology
Published: July 09, 2019
Transfusion practices and complications in thalassemia.
Journal: Transfusion
Published: December 07, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026